Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism

BACKGROUND: Endothelin 1 (ET‐1) contributes to chronic kidney disease (CKD) development and progression, and endothelin receptor antagonists are being investigated as a novel therapy for CKD. The proET‐1 peptides, endothelin‐like domain peptide (ELDP) and C‐terminal pro‐ET‐1 (CT‐proET‐1), are both p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhaun, Neeraj, Yuzugulen, Jale, Kimmitt, Robert A., Wood, Elizabeth G., Chariyavilaskul, Pajaree, MacIntyre, Iain M., Goddard, Jane, Webb, David J., Corder, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392442/
https://www.ncbi.nlm.nih.gov/pubmed/25801761
http://dx.doi.org/10.1161/JAHA.114.001624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392442/
https://www.ncbi.nlm.nih.gov/pubmed/25801761
http://dx.doi.org/10.1161/JAHA.114.001624

Ejemplares similares